Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy

Bradley S Ferguson1, Brooke C Harrison, Mark Y Jeong

  • 1Division of Cardiology, Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA.

Insights

Class I histone deacetylase (HDAC) inhibitors suppress cardiac hypertrophy by regulating dual-specificity phosphatase 5 (DUSP5). This mechanism involves a self-reinforcing loop controlling prohypertrophic ERK signaling in heart cells.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Epigenetics

Background:

  • Cardiac hypertrophy is a significant risk factor for heart failure morbidity and mortality.
  • The precise molecular mechanisms by which histone deacetylase (HDAC) inhibitors suppress cardiac hypertrophy are not fully understood.

Purpose of the Study:

  • To elucidate the role of class I HDACs and dual-specificity phosphatase 5 (DUSP5) in regulating cardiac hypertrophy.
  • To investigate the signaling pathways involved in HDAC inhibition-mediated suppression of cardiac hypertrophy.

Main Methods:

  • Utilized selective class I HDAC inhibitors in cardiac myocytes.
  • Investigated the expression and activity of DUSP5 and ERK1/2 signaling pathways.
  • Employed ectopic expression of DUSP5 in cardiomyocytes.

Main Results:

  • Class I HDACs repress cardiac hypertrophy by inhibiting DUSP5 gene expression.
  • DUSP5 acts as a nuclear phosphatase, negatively regulating prohypertrophic ERK1/2 signaling.
  • HDAC inhibition of DUSP5 requires MEK activity, establishing a positive feedback loop for ERK signaling.

Conclusions:

  • Class I HDACs and DUSP5 are key components of a regulatory circuit controlling cardiac hypertrophy.
  • DUSP5 plays a critical role in suppressing agonist-induced cardiac hypertrophy.
  • Targeting this HDAC-DUSP5-ERK pathway may offer therapeutic strategies for heart failure.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...